-
Insulin Plus Metformin vs Triple Oral Therapy in Type 2 Diabetes; ARB
and ACE-I in Diabetic Nephropathy; Low-Glycemic Index Diets and
Diabetes; Ultralow-Dose Estrogen and Bone in Older Women; Effect of
Intensity of Oral Anticoagulation in Atrial Fibrillation; Patient
Knowledge and Awareness of Hypertension
-
A generic form of paroxetine (PaxilGlaxoSmithKline) will soon be on the market. The drug marks the second SSRI antidepressant to go generic after fluoxetine (Prozac) last year.
-
Thomson American Health Consultants offers the upcoming audio conference: The Resurgence of SARS: Why your hospital may not be as prepared as you think, on Dec. 9, from 2:30-3:30 EST.
-
EMTALA: The Essential Guide to Compliance from Thomson American Health Consultants, publisher of Emergency Medicine Reports, explains how the changes to EMTALA will affect emergency departments and off-campus clinics.
-
The ED physician and trauma surgeon must have evidence-based
information on indications for emergency department thoracotomy that
can be determined rapidly, easily accessible equipment, and the ability
to recognize situations in which EDT clearly is not in the patients
best interest.
-
-
Most postmenopausal women who suffer a fracture do not receive treatment for osteoporosis.
-
The FDA has approved the first drug for the treatment of moderate-to-severe Alzheimers disease. Memantine, a noncompetitive inhibitor of the N-methyl-D-aspartate receptor, has been available outside of the United States since 1982.
-
Parathyroid Hormone and Alendronate Alone or in Combination in Postmenopausal Osteoporosis; Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis; Exercise Testing to Predict Cardiovascular and All-Cause Death in Women
-
Exercise reduces the risk of breast cancer after menopause. Although the exercise need not be strenuous, longer duration of exercise confers greater benefit.
